Potential for modest differences between sexes in antiretroviral therapy pharmacokinetics and adverse events

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.22, Iss.11, 2006-11, pp. : 22-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sex Differences in Antiretroviral Therapy-Associated Intolerance and Adverse Events

By Clark Rebecca

Drug Safety, Vol. 28, Iss. 12, 2005-01 ,pp. : 1075-1083

Adis International

Access to resources Recommend Favorite

Sex differences in pharmacokinetics and toxicity of antiretroviral therapy

By Umeh Obiamiwe C Currier Judith S

Expert Opinion on Drug Metabolism and Toxicology, Vol. 2, Iss. 2, 2006-04 ,pp. : 273-283

Informa Healthcare

Access to resources Recommend Favorite

Understanding and Avoiding Antiretroviral Adverse Events

Current Pharmaceutical Design, Vol. 12, Iss. 9, 2006-03 ,pp. : 1075-1090

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetics of Antiretroviral Therapy in HIV-1-Infected Children

By Fraaij Pieter L.A. van Kampen Jeroen J.A. Burger David M. Ronald de Groot

Clinical Pharmacokinetics, Vol. 44, Iss. 9, 2005-01 ,pp. : 935-956

Adis International

Access to resources Recommend Favorite

Adverse effects of antiretroviral therapy: focus on bone density

By Viganò Alessandra Mora Stefano

Expert Opinion on Drug Safety, Vol. 3, Iss. 3, 2004-05 ,pp. : 199-208

Informa Healthcare

Access to resources Recommend Favorite